AG
RDY icon

Ashmore Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Ashmore Group’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-25,200
Closed -$228K – 41
2016
Q1 		$228K Hold
25,200
– – 0.14% 36
2015
Q4 		$233K Buy
+25,200
New +$276K 0.15% 47
2014
Q4 		– Sell
-1,023,160
Closed -$10.8M – 65
2014
Q3 		$10.8M Sell
1,023,160
-464,140
-31% -$4.36M 2.1% 18
2014
Q2 		$12.8M Buy
+1,487,300
New +$12.5M 1.7% 20
2014
Q1 		– Sell
-199,970
Closed -$1.64M – 71
2013
Q4 		$1.64M Buy
199,970
+49,970
+33% +$396K 0.33% 24
2013
Q3 		$1.13M Sell
150,000
-763,540
-84% -$5.55M 0.15% 35
2013
Q2 		$6.91M Buy
+913,540
New +$6.67M 1.01% 16

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ashmore Group's RDY Position: Q2 2016 in Review

Ashmore Group sold out of Dr. Reddy's Laboratories (RDY) in Q2 2016, closing a stake of 25,200 shares — an estimated $228K sold.

Ashmore Group first reported a position in RDY in Q2 2013 and held it in 7 quarters. The position peaked at $12.8M in Q2 2014. 157 funds tracked by Wall St. Rank hold RDY as of Q2 2016.

  • Ashmore Group reported no remaining Dr. Reddy's Laboratories position as of Q2 2016 after selling out during the quarter.
  • Ashmore Group sold 25,200 Dr. Reddy's Laboratories shares in Q2 2016, an estimated $228K.
  • Ashmore Group first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 7 quarters.
  • Ashmore Group's Dr. Reddy's Laboratories position peaked at $12.8M in Q2 2014.
  • 157 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2016.

Based on Ashmore Group's 13F filing for Q2 2016, filed 15 Aug 2016.